Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane Duryea

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Cell Science|April 8, 2003
Macroscopic cartilage formation with embryonic stem-cell-derived mesodermal progenitor cellsNaoki Nakayama, Diane Duryea, Raffi Manoukian, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 20, 2008
The evolving systemic and local biomarker milieu at different stages of disease progression in rat collagen-induced arthritisMarina Stolina, Brad Bolon, Denise Dwyer, et al.
Arthritis Research & Therapy|December 17, 2009
RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapiesMarina Stolina, Georg Schett, Denise Dwyer, et al.
Journal of Clinical Immunology|August 30, 2008
The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritisMarina Stolina, Brad Bolon, Scot Middleton, et al.
Arthritis and Rheumatism|October 18, 2002
Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritisAngela Coxon, Brad Bolon, Juan Estrada, et al.
Development (Cambridge, England)|December 9, 2003
A novel chordin-like BMP inhibitor, CHL2, expressed preferentially in chondrocytes of developing cartilage and osteoarthritic joint cartilageNaoki Nakayama, Chun-ya E Han, Linh Cam, et al.
Toxicologic Pathology|June 19, 2004
The candidate neuroprotective agent artemin induces autonomic neural dysplasia without preventing peripheral nerve dysfunctionBrad Bolon, Shuqian Jing, Frank Asuncion, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Cell Science|April 8, 2003
Macroscopic cartilage formation with embryonic stem-cell-derived mesodermal progenitor cellsNaoki Nakayama, Diane Duryea, Raffi Manoukian, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 20, 2008
The evolving systemic and local biomarker milieu at different stages of disease progression in rat collagen-induced arthritisMarina Stolina, Brad Bolon, Denise Dwyer, et al.
Arthritis Research & Therapy|December 17, 2009
RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapiesMarina Stolina, Georg Schett, Denise Dwyer, et al.
Journal of Clinical Immunology|August 30, 2008
The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritisMarina Stolina, Brad Bolon, Scot Middleton, et al.
Arthritis and Rheumatism|October 18, 2002
Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritisAngela Coxon, Brad Bolon, Juan Estrada, et al.
Development (Cambridge, England)|December 9, 2003
A novel chordin-like BMP inhibitor, CHL2, expressed preferentially in chondrocytes of developing cartilage and osteoarthritic joint cartilageNaoki Nakayama, Chun-ya E Han, Linh Cam, et al.
Toxicologic Pathology|June 19, 2004
The candidate neuroprotective agent artemin induces autonomic neural dysplasia without preventing peripheral nerve dysfunctionBrad Bolon, Shuqian Jing, Frank Asuncion, et al.
Pageof 1